May 14, 2020 / 10:54 AM / 14 days ago

BRIEF-Tcr² Therapeutics Reports Q1 2020 Financial Results

May 14 (Reuters) - TCR2 Therapeutics Inc:

* TCR² THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* QTRLY LOSS PER SHARE $0.65

* ENDED Q1 OF 2020 WITH $140.7 MILLION IN CASH, CASH EQUIVALENTS, AND INVESTMENTS

* PROJECTS NET CASH USE OF $60-70 MILLION FOR 2020

* UPDATING OUR TC-210 GUIDANCE TO EXPECT AN INTERIM UPDATE FROM PHASE 1 PORTION IN MID-2020

* Q1 EARNINGS PER SHARE VIEW $-0.61 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below